Delivery Order SPE2DX22D0029-SPE2D825F34XT
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,296.75 by the Defense Logistics Agency's Medical Supply Chain on July 16, 2025, with an ultimate completion date of July 17, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,035.44 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, with a completion date of July 15, 2025. This firm fixed-price, non-set-aside delivery order represents a small-value transaction under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order will be performed at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $35,097.32 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside delivery order operates under firm fixed pricing and represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The work will be...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $10,873.56 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency's Medical Supply Chain division, with an ultimate completion date of September 4, 2025. This non-competitive, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a potential value of $999,999,999.00 through December 2026. The work will be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,379.98 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 17, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $175,587.80 by the Defense Logistics Agency's Medical Supply Chain on June 30, 2025, with an ultimate completion date of July 1, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The delivery order will be performed at AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,247.80 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This competitively awarded, firm fixed-price delivery order is unset-aside and has an ultimate completion date of September 9, 2025. The contract represents a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,974.65 by the Defense Logistics Agency's Medical Supply Chain on July 4, 2025, with an ultimate completion date of July 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's extensive federal pharmaceutical supply portfolio. The delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $149,249.63 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract is performed at the awardee's corporate office...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D825F34XTDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,454.56 by the Defense Logistics Agency's Medical Supply Chain on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The company, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is executed under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a primary pharmaceutical distributor for federal military and veteran healthcare systems, AmerisourceBergen supplies a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/10/25 |